ArticleJTO clinical and research reports2026

Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief Report.

Adele Bonato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.